Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 81, Issue 3, 2002, Pages 148-154

  Ikeguchi, Masahide ^a   Ueta, Tsuyoshi ^a   Yamane, Yoshiaki ^a   Hirooka, Yasuaki ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cancer recurrence; Clinicopathological finding; Prognosis; Real time reverse transcriptase polymerase chain reaction

Indexed keywords

HEPARANASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENZYME RELEASE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GLUCURONIDASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036828920     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10163     Document Type: Article

References (18)

1. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;21:277-287.
2. Mise K, Tashiro S, Yogita S, et al.: Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998;4:1475-1482.
3. Tanaka D, Toh Y, Adachi E, et al.: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993;53:2884-2887.
4. Piao Z, Kim H, Jeon BK, et al.: Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 1997;80:865-872.
5. Hulett MD, Freeman C, Hamdorf BJ, et al.: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999;5:803-809.
6. Marchetti D, Li J, Shen R: Astrocytes contribute to the brainmetastasis specificity of melanoma cells by producing heparanase. Cancer Res 2000;60:4767-4770.
7. Ikuta M, Podyma KA, Maruyama K, et al.: Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol 2001;37:177-184.
8. Mikami S, Ohashi K, Usui Y, et al.: Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 2001;92:1062-1073.
9. Koliopanos A, Friess H, Kleeff J, et al.: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001;61:4655-4659.
10. Cheung IY, Cheung NV: Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR. Clin Cancer Res 2001;7:1698-1705.
11. Yajima T, Yagihashi A, Kameshima H, et al.: Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem 1998;44:2441-2445.
12. Mitas M, Mikhitarian K, Walters C, et al.: Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001;93:162-171.
13. Liver Cancer Study Group of Japan. "Classification of Primary Liver Cancer." 1st English Edition. Tokyo: Kanehara; 1997.
14. Nakajima M, Irimura T, Di Ferrante N, et al.: Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 1982;259:2283-2290.
15. El-Assal ON, Yamanoi A, Ono T, et al.: The clinicopathological significance of heparanase and basic fibroblast growth factor expression in hepatocellular carcinoma. Clin Cancer Res 2001;7:1299-1305.
16. Suzuki R, Takemura K, Tsutsumi M, et al.: Detection of cyclin D1 overexpression by real-time reverse-transcriptase-method quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma. Am J Pathol 2001;159:425-429.
17. Ogawa K, Nakanishi H, Takeshita F, et al.: Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice. Int J Cancer 2001;91:797-802.
18. Feitelson MA, Sun B, Tufan NLS, et al.: Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002;21:2593-2604.